Literature DB >> 33302735

Nomograms-based prediction of overall and cancer-specific survivals for patients with chromophobe renal cell carcinoma.

Chunyang Chen1, Xinyu Geng1, Rui Liang1, Dongze Zhang2,3, Meiyun Sun2,3, Guangbo Zhang2,3, Jianquan Hou1.   

Abstract

This study built and tested two effective nomograms for the purpose of predicting cancer-specific survival and overall survival of chromophobe renal cell carcinoma (chRCC) patients. Multivariate Cox regression analysis was employed to filter independent prognostic factors predictive of cancer-specific survival and overall survival, and the nomograms were built based on a training set incorporating 2901 chRCC patients in a retrospective study (from 2004 to 2015) downloaded from the surveillance, epidemiology, and end results (SEER) database. The nomograms were verified on a validation cohort of 1934 patients, subsequently the performances of the nomograms were examined according to the receiver operating characteristic curve, calibration curves, the concordance (C-index), and decision curve analysis. The results showed that tumor grade, AJCC and N stages, race, marital status, age, histories of chemotherapy, radiotherapy and surgery were the individual prognostic factors for overall survival, and that AJCC, N and SEER stages, histories of surgery, radiotherapy and chemotherapy, age, tumor grade were individual prognostic factors for cancer-specific survival. According to C-indexes, receiver operating characteristic curves, and decision curve analysis outcomes, the nomograms showed a higher accuracy in predicting overall survival and OSS when compared with TNM stage and SEER stage. All the calibration curves were significantly consistent between predictive and validation sets. In this study, the nomograms, which were validated to be highly accurate and applicable, were built to facilitate individualized predictions of the cancer-specific survival and overall survival to patients diagnosed with chRCC between 2004 and 2015.

Entities:  

Keywords:  Nomogram; SEER; cancer-specific survival; chromophobe renal cell carcinoma; overall survival; prognosis

Mesh:

Year:  2020        PMID: 33302735      PMCID: PMC7988723          DOI: 10.1177/1535370220977107

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  31 in total

1.  Lymph Node Density as an Independent Prognostic Factor in Node-Positive Renal-Cell Carcinoma: Results From the Surveillance, Epidemiology, and End Results Program.

Authors:  Xinyang Liao; Shi Qiu; Xiaonan Zheng; Jianzhong Ai; Xi Jin; Lina Gong; Yige Bao; Kun Jin; Huifang Li; Lu Yang; Qiang Wei
Journal:  Clin Genitourin Cancer       Date:  2019-05-27       Impact factor: 2.872

2.  Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement.

Authors:  Umang Swami; Roberto H Nussenzveig; Benjamin Haaland; Neeraj Agarwal
Journal:  Ann Transl Med       Date:  2019-03

3.  Development and validation of an integrative methylation signature and nomogram for predicting survival in clear cell renal cell carcinoma.

Authors:  Qiliang Peng; Yibin Zhou; Lu Jin; Cheng Cao; Cheng Gao; Jianfang Zhou; Dongrong Yang; Jin Zhu
Journal:  Transl Androl Urol       Date:  2020-06

4.  Nomograms for predicting overall and cancer-specific survival in patients with papillary renal cell carcinoma: a population-based study using SEER database.

Authors:  Haicui Yan; Xiyi Wei; Aimin Wu; Yeqin Sha; Xiao Li; Feng Qi
Journal:  Transl Androl Urol       Date:  2020-06

5.  Racial difference in histologic subtype of renal cell carcinoma.

Authors:  Andrew F Olshan; Tzy-Mey Kuo; Anne-Marie Meyer; Matthew E Nielsen; Mark P Purdue; W Kimryn Rathmell
Journal:  Cancer Med       Date:  2013-08-06       Impact factor: 4.452

Review 6.  Genomics of chromophobe renal cell carcinoma: implications from a rare tumor for pan-cancer studies.

Authors:  Kimryn W Rathmell; Fengju Chen; Chad J Creighton
Journal:  Oncoscience       Date:  2015-02-20

7.  Marital status and survival in patients with renal cell carcinoma.

Authors:  Yan Li; Ming-Xi Zhu; Si-Hua Qi
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

8.  Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution.

Authors:  Jun Zhou; Xiaoqun Yang; Luting Zhou; Peipei Zhang; Chaofu Wang
Journal:  Dis Markers       Date:  2019-10-13       Impact factor: 3.434

9.  Prognostic Value of Clinical and Pathological Features in Chinese Patients with Chromophobe Renal Cell Carcinoma: A 10-Year Single-Center Study.

Authors:  Yongpeng Xie; Xin Ma; Hongzhao Li; Yu Gao; Liangyou Gu; Luyao Chen; Xu Zhang
Journal:  J Cancer       Date:  2017-09-27       Impact factor: 4.207

10.  Sites of synchronous distant metastases and prognosis in prostate cancer patients with bone metastases at initial diagnosis: a population-based study of 16,643 patients.

Authors:  Feng Zhao; Jili Wang; Meiqin Chen; Danni Chen; Sunyi Ye; Xinke Li; Xin Chen; Guoping Ren; Senxiang Yan
Journal:  Clin Transl Med       Date:  2019-11-29
View more
  2 in total

1.  Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer.

Authors:  Shengtao Dong; Hua Yang; Zhi-Ri Tang; Yuqi Ke; Haosheng Wang; Wenle Li; Kang Tian
Journal:  Front Oncol       Date:  2021-11-25       Impact factor: 6.244

2.  Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study.

Authors:  Jinkui Wang; Chenghao Zhanghuang; Xiaojun Tan; Tao Mi; Jiayan Liu; Liming Jin; Mujie Li; Zhaoxia Zhang; Dawei He
Journal:  Front Public Health       Date:  2022-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.